Nvidia is trading at a rare valuation discount despite record fundamentals and strong AI demand. Is the AI leader becoming a ...
Oberbeck emphasized the importance of "balance sheet strength, liquidity and NAV preservation" amid ongoing volatility.
Novo Nordisk is my top opportunity for 2026, driven by multiple catalysts and a compelling valuation. The Wegovy pill's FDA ...